Iterum Therapeutics (ITRM)

• Market cap: $14M
• 1 day: 30.15%
• 5 days: 0.65%
• 1 month: -21.64%
• 3 months: -37.4%
• 6 months: -63.54%
• Year to date: -16.41%
• 1 year: -81.99%
• 5 years: -99.08%
• 10 years: -99.86%
• Sector: Healthcare
• Industry: Biotechnology

About: Iterum Therapeutics PLC is a pharmaceutical company dedicated to maximizing the commercial potential of Orlynvah, an oral-branded penem available in the United States and potentially the first and only oral and intravenous (IV) branded penem available globally. Its product Orlynvah has the potential to be a treatment for complicated urinary tract infections caused by the designated microorganisms, without the presence of known toxicities of some other antibiotics. The company operates in a single business segment, which is the development and commercialization of treatments for drug-resistant bacterial infections.

Employees: 9